| Literature DB >> 31931614 |
Olesya Didyuk1, Nicolas Econom2, Angelica Guardia2, Kelsey Livingston2, Ulrike Klueh2.
Abstract
The concept of implantable glucose sensors has been promulgated for more than 40 years. It is now accepted that continuous glucose monitoring (CGM) increases quality of life by allowing informed diabetes management decisions as a result of more optimized glucose control. The focus of this article is to provide a brief overview of the CGM market history, emerging technologies, and the foreseeable challenges for the next CGM generations as well as proposing possible solutions in an effort to advance the next generation of implantable sensor.Entities:
Keywords: continuous glucose monitoring; diabetes; foreign body reaction; inflammation
Mesh:
Substances:
Year: 2020 PMID: 31931614 PMCID: PMC8120065 DOI: 10.1177/1932296819899394
Source DB: PubMed Journal: J Diabetes Sci Technol ISSN: 1932-2968